Why the SpaceX IPO now carries more chip execution risk
According to Reuters’ review of SpaceX’s S-1 filing, the company listed manufacturing its own GPUs among substantial capital expenditures and warned that continued dependence on outside compute suppliers could slow or even derail its Terafab objectives. That is a striking disclosure for any IPO candidate because advanced chip production is one of the hardest businesses in technology, demanding huge upfront investment, reliable supply relationships and flawless execution over long timelines.
That makes the risk less about whether SpaceX can raise money and more about what public investors would actually be funding. If the company remains primarily a launch, satellite and connectivity business, the valuation case rests on businesses investors can already model. If it is also becoming a chipmaker and a major AI infrastructure builder, the upside gets bigger, but so do the timelines, costs and failure points.
The shift is even more important because Reuters reported separately that SpaceX now sees most of its addressable market in AI, not in space transportation. The same report said xAI lost $6.4 billion in 2025 while companywide capital expenditures rose to $20.7 billion, with AI accounting for $12.7 billion. In other words, the IPO story is increasingly being priced as an AI expansion narrative, even though the spending burden is already rising faster than many investors may have expected.
Terafab could widen the upside and the bill
The Terafab angle is what turns this from an ambitious product story into a balance-sheet story. Reuters reported that Tesla plans to use Intel’s next-generation 14A process for Terafab, the Austin chip project Musk has framed around automotive, robotics and space-related compute. That gives the initiative more industrial credibility, but it does not answer the questions investors will likely care about most: who pays for the most expensive fabrication equipment, who operates the facilities, how quickly output can ramp and how much of the execution risk ultimately sits with SpaceX after the listing.
For SpaceX, the strategic logic is easy to understand. Owning more of the AI hardware stack could reduce long-term dependence on suppliers, give Musk’s companies tighter control over cost and performance, and let SpaceX participate in a much larger share of the value created by enterprise AI. But the nearer-term reality is harsher. Every step toward in-house silicon adds exposure to an industry where delays are common, margins can be volatile and even well-funded incumbents routinely stumble.
That tension is why the SpaceX IPO story is becoming harder to slot into a single bucket. Bulls can argue that a company with launch leadership, Starlink scale and AI ambition deserves a premium multiple. Skeptics can argue that public investors are being asked to finance an increasingly broad industrial experiment that stretches well beyond the company’s proven businesses.
SpaceX IPO context: this bet did not appear overnight
The arc also looks more credible — and more risky — when viewed over time. In June 2024, Reuters reported that Musk redirected Nvidia chips originally reserved for Tesla to X and xAI, an early signal that compute had become a strategic bottleneck inside his wider business empire. In November 2024, Reuters reported that SpaceX was preparing a tender offer at $135 a share, showing private-market investors were already willing to mark the company sharply higher before the current IPO push. And in December 2025, Reuters reported that xAI was expanding toward nearly 2 gigawatts of compute power and at least 1 million GPUs, underscoring how quickly the demand for AI infrastructure was scaling before SpaceX’s GPU ambitions surfaced in the IPO narrative.
Seen that way, the latest disclosure is less a surprise than a culmination. The real issue is not whether Musk wants SpaceX to be a bigger AI player. It is whether public-market investors will accept the cost profile and execution risk that come with turning that ambition into a semiconductor strategy.
If SpaceX can show that Terafab will be phased, disciplined and backed by credible manufacturing partners, the AI angle could strengthen the IPO case. If that clarity does not arrive soon, the GPU push risks becoming the most expensive uncertainty attached to the offering — and the factor most likely to force investors to demand a wider margin of safety.
